PATENT CLAIM ANALYSIS

Application Number: 15901467
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-10
Patent Classification: ["514", "177000"]

Abstract:
This disclosure provides a novel pharmaceutical composition for delivering steroid hormones to a patient in need thereof.

Claim (Index 32):
The method of  claim 28 , wherein the disease or condition associated with reduced progesterone levels is selected from the group consisting of menopause, endometrial hyperplasia; secondary amenorrhea; prevention of preterm birth; and osteoporosis.

Metadata:
- Claim Count in Document: 44.0
- Percentile: 88.0
- Lexical Diversity: 1.05882
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15473733', '15473742', '10074687', '15454898', '10428341']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8001961261509783
- 35 USC 102 Novelty (BERT): 0.6550571336366415
- Combined Prediction Score: 0.7856822268995447
- Mean Citation Score: 399.875624
- Max Citation Score: 712.5666
- Similarity Product: 580.3365068142058

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test